LXEO
Lexeo Therapeutics, Inc.
3.40$
-3.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +6.5% | -2.9% | +4.2% | +2.6% | – | – | +1.8% | +3.9% | +1.5% | +1.5% | – | – | |
| – | – | – | – | – | – | -151.5% | – | – | – | – | – | – | |
| – | -52.4% | +91.7% | +5.2% | +41.4% | -21.6% | -6.5% | -14.3% | +6.6% | +3.3% | -3.1% | +21.2% | – | |
| – | +123.5% | +11.6% | -7.4% | +16.2% | +11.0% | +84.5% | -4.0% | -62.7% | +16.0% | -4.0% | +35.6% | – | |
| – | -26.1% | +55.5% | +1.1% | +33.9% | -13.2% | +23.5% | -9.2% | -29.5% | +6.8% | -5.7% | +28.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.8% | -26.0% | -5.4% | +0.0% | -14.3% | +33.3% | +47.5% | +39.0% | -69.5% | -32.0% | -17.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.9% | -25.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.